Multiple Infections and Cancer: Implications in Epidemiology
暂无分享,去创建一个
Mukesh Verma | V. Vedham | M. Verma | Vaurice L Starks | Vidya Vedham | Rao L. Divi | Vaurice L. Starks | R. Divi
[1] D. Lowy,et al. Reducing HPV-Associated Cancer Globally , 2012, Cancer Prevention Research.
[2] F. Bray,et al. Chapter 2: The burden of HPV-related cancers. , 2006, Vaccine.
[3] J. Everhart,et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. , 2000, The Journal of infectious diseases.
[4] A. Carbone,et al. Why would the incidence of HIV‐associated Hodgkin lymphoma increase in the setting of improved immunity? , 2007, International journal of cancer.
[5] E. Robertson,et al. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention , 2010, Cancer biology & therapy.
[6] F. X. Bosch,et al. Environmental co-factors in HPV carcinogenesis. , 2002, Virus research.
[7] J. Gutkind,et al. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer , 2008, Oncogene.
[8] M. Lehtinen,et al. Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia , 2011, Sexually Transmitted Infections.
[9] M. Siddiqui,et al. Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) , 2012, Drugs.
[10] A. Kebede,et al. Assessment of public health implication of malaria-geohelminth co-infection with an emphasis on hookworm-malaria anemia among suspected malaria patients in asendabo, southwest Ethiopia. , 2009, Ethiopian medical journal.
[11] H. zur Hausen,et al. Papillomaviruses in the causation of human cancers - a brief historical account. , 2009, Virology.
[12] C. Boshoff,et al. Aids-related malignancies , 2002, Nature Reviews Cancer.
[13] M. Blaser,et al. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. , 1999, The Journal of infectious diseases.
[14] G. Landman,et al. A review of the epidemiology and treatment of Merkel cell carcinoma , 2011, Clinics.
[15] Lewis R. Roberts,et al. Hepatocellular carcinoma: a global view , 2010, Nature Reviews Gastroenterology &Hepatology.
[16] A. Singal,et al. Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. , 2009, World journal of gastroenterology.
[17] M. Bozzetti,et al. Chlamydia trachomatis and human papillomavirus coinfection: association with p16INK4a and Ki67 expression in biopsies of patients with pre-neoplastic and neoplastic lesions. , 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[18] E. Auvinen,et al. Human papillomavirus and Epstein-Barr virus in epithelial carcinomas of the head and neck region. , 1997, Anticancer research.
[19] Harpreet K. Monga,et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[20] C J L M Meijer,et al. The causal relation between human papillomavirus and cervical cancer. , 2002, Journal of clinical pathology.
[21] P. E. Simonsen,et al. Cross-sectional relationship between HIV, lymphatic filariasis and other parasitic infections in adults in coastal northeastern Tanzania. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[22] C. Lacey,et al. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts , 2000, Sexually transmitted infections.
[23] A. Dempsey,et al. The role of HPV in head and neck cancer and review of the HPV vaccine. , 2011, Preventive medicine.
[24] K. Rolston. The spectrum of pulmonary infections in cancer patients , 2001, Current opinion in oncology.
[25] M. Gandhi,et al. Epstein–Barr Virus‐Related Post‐Transplant Lymphoproliferative Disorders: Pathogenetic Insights for Targeted Therapy , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] L. Dai,et al. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. , 1998, International journal of epidemiology.
[27] A. De Luca,et al. Helicobacter pylori and gastric diseases: a dangerous association. , 2004, Cancer letters.
[28] S. Chevaliez. Virological tools to diagnose and monitor hepatitis C virus infection. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[29] A. Axon,et al. Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications , 1999, Gut.
[30] L. Young,et al. Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.
[31] Yan Liu,et al. Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment , 2010, Environmental health perspectives.
[32] C. V. D. Bosch,et al. Is endemic Burkitt's lymphoma an alliance between three infections and a tumour promoter? , 2004 .
[33] Y. Yamaoka,et al. Epidemiology of Helicobacter pylori Infection and Public Health Implications , 2011, Helicobacter.
[34] D. Lavanchy,et al. Evolving epidemiology of hepatitis C virus. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[35] A. Jemal,et al. Global Cancer Statistics , 2011 .
[36] Mamun-Al-Mahtab. State of the Globe: Helicobacter pylori and Hepatitis C Together Hamper Health , 2010, Journal of global infectious diseases.
[37] R. Peek,et al. Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.
[38] A. Moormann,et al. The company malaria keeps: how co-infection with Epstein–Barr virus leads to endemic Burkitt lymphoma , 2011, Current opinion in infectious diseases.
[39] P. Hufnagl,et al. Novel Real-Time PCR Assay for Detection of Helicobacter pylori Infection and Simultaneous Clarithromycin Susceptibility Testing of Stool and Biopsy Specimens , 2004, Journal of Clinical Microbiology.
[40] M. Gill,et al. Changing mortality rates and causes of death for HIV‐infected individuals living in Southern Alberta, Canada from 1984 to 2003 , 2005, HIV medicine.
[41] M. Falagas,et al. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[42] D. Graham,et al. H. pylori and cagA: Relationships with Gastric Cancer, Duodenal Ulcer, and Reflux Esophagitis and Its Complications , 1998, Helicobacter.
[43] Johnm . Taylor,et al. Origin of hepatitis delta virus. , 2010, Future microbiology.
[44] L. Bravo,et al. Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[45] J. Sham,et al. Nasopharyngeal carcinoma , 2005, The Lancet.
[46] D. Parkin,et al. The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.
[47] J. Slansky,et al. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. , 2012, Anticancer research.
[48] D. Lowy,et al. Vaccines to prevent infections by oncoviruses. , 2010, Annual review of microbiology.
[49] Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) , 2012, Drugs.
[50] J. Emparanza,et al. [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.
[51] A. Moormann,et al. Endemic Burkitt's lymphoma: a polymicrobial disease? , 2005, Nature Reviews Microbiology.
[52] A. Jemal,et al. The global burden of cancer: priorities for prevention , 2009, Carcinogenesis.
[53] H. Hausen. Viruses in human cancers , 1991 .
[54] Tara L. Kieffer,et al. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .
[55] P. Correa,et al. Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.
[56] F. Mégraud,et al. Diagnosis of Helicobacter pylori Infection , 2010, Helicobacter.
[57] M. Plebani,et al. H. pylori Infection: Bacterial Virulence Factors and Cytokine Gene Polymorphisms as Determinants of Infection Outcome , 2004, Critical reviews in clinical laboratory sciences.
[58] C. Wild,et al. Mycotoxins and Human Disease: a Largely Ignored Global Health Issue , 2022 .
[59] B. Tepes. Can gastric cancer be prevented? , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[60] D. Cave,et al. How is Helicobacter pylori transmitted? , 1997, Gastroenterology.
[61] L. Kinlen. Infections and immune factors in cancer: the role of epidemiology , 2004, Oncogene.
[62] Junji Furuse,et al. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. , 2010, The oncologist.
[63] A. Rickinson,et al. Immune defence against EBV and EBV-associated disease. , 2011, Current opinion in immunology.
[64] C. González,et al. Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go , 2012, International journal of cancer.
[65] T. Hibi,et al. Helicobacter pylori eradication therapy. , 2010, Future microbiology.
[66] M. Zalla. Kaposi's Sarcoma An Update , 1996, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[67] A. Elbasmy,et al. Contribution of hepatitis C virus and Helicobacter Pylori co-infection as possible predisposing factors in the occurrence of gastric mucosal dysplasia. , 2004, Journal of the Egyptian National Cancer Institute.
[68] B. O'Sullivan,et al. Epstein–Barr virus-associated tumours: an update for the attention of the working pathologist , 2006, Journal of Clinical Pathology.
[69] S. Wacholder,et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. , 2010, Journal of the National Cancer Institute.
[70] S. Tyring,et al. AIDS malignancies. , 2007, Cancer treatment and research.
[71] Andrew Y. Wang,et al. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. , 2011, Gastrointestinal endoscopy clinics of North America.
[72] J. Parsonnet. The incidence of Helicobacter pylori infection. , 1995, Alimentary pharmacology & therapeutics.
[73] E. Pirog,et al. Comprehensive analysis of Human Papillomavirus and Chlamydia trachomatis in in-situ and invasive cervical adenocarcinoma. , 2009, Gynecologic oncology.
[74] S. Franceschi,et al. Infections and cancer: established associations and new hypotheses. , 2009, Critical reviews in oncology/hematology.
[75] M. Chiasson,et al. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study , 2002, The Lancet.
[76] K. Anastos,et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. , 2005, Journal of the National Cancer Institute.
[77] P. Salehian,et al. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization. , 2005, Experimental and molecular pathology.
[78] R. Tur-kaspa,et al. The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma. , 2011, Clinics in liver disease.
[79] F. Mégraud,et al. Diagnosis of Helicobacter pylori Infection , 2006, Helicobacter.
[80] D. Lowy,et al. Assessing the Burden of HPV-Associated Cancers in the United States HPV Prophylactic Vaccines and the Potential Prevention of Noncervical Cancers in Both Men and Women , 2008 .
[81] S. Bhagani,et al. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections. , 2003, Journal of HIV therapy.
[82] M. Weltman,et al. Coinfection with hepatitis B and C or B, C and δ viruses results in severe chronic liver disease and responds poorly to terferon‐a treatment , 1995 .
[83] M. Wierzbicka,et al. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas , 2002, Clinical and Experimental Medicine.
[84] V. Gorgoulis,et al. Advances in the biology of oral cancer. , 2007, Oral oncology.
[85] S. Rai,et al. Significance of multiple HPV infection in cervical cancer patients and its impact on treatment response. , 2009, International journal of oncology.
[86] E. Franco,et al. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. , 2011, Preventive medicine.
[87] Francesco Donato,et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. , 2004, Gastroenterology.
[88] S. Banks,et al. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B , 1991, Hepatology.
[89] A. Jemal,et al. Cancer burden in Africa and opportunities for prevention , 2012, Cancer.
[90] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[91] D. Serraino,et al. HIV-associated Hodgkin lymphoma. , 2009, Current opinion in HIV and AIDS.
[92] F. X. Bosch,et al. Aflatoxin, hepatitis and worldwide liver cancer risks. , 2002, Advances in experimental medicine and biology.
[93] W. Almawi,et al. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. , 2002, Diagnostic microbiology and infectious disease.
[94] E. Kieff,et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes , 1990, Journal of virology.
[95] W. Melchers,et al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer , 2004, Reviews in medical virology.
[96] G. Niedobitek,et al. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma. , 1996, Seminars in cancer biology.
[97] A. Mbonye,et al. Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: A systematic review , 2011, Infectious Agents and Cancer.
[98] P. Wallace,et al. Role of cervical dendritic cell subsets, co-stimulatory molecules, cytokine secretion profile and beta-estradiol in development of sequalae to Chlamydia trachomatis infection , 2008, Reproductive biology and endocrinology : RB&E.
[99] M. Bouchard,et al. Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges. , 2011, Cancer letters.
[100] F. X. Bosch,et al. Human papillomavirus: science and technologies for the elimination of cervical cancer , 2011, Expert opinion on pharmacotherapy.
[101] Tao Shang,et al. Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformation , 2008, BMC Genomics.
[102] B. Dal Bello,et al. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. , 2009, Gynecologic oncology.
[103] David L. Thomas,et al. The challenge of hepatitis C in the HIV-infected person. , 2008, Annual review of medicine.
[104] S. Tsuchiya. Diagnosis of Epstein-Barr virus-associated diseases. , 2002, Critical reviews in oncology/hematology.
[105] J. T. Thigpen. Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia , 2007 .
[106] T. Azuma,et al. Distinct Diversity of vacA, cagA, and cagE Genes of Helicobacter pylori Associated with Peptic Ulcer in Japan , 2005, Journal of Clinical Microbiology.
[107] P. Farrell,et al. The role of Epstein–Barr virus in cancer , 2006, Expert opinion on biological therapy.
[108] S. Sanjosé,et al. Human papillomavirus in cervical cancer , 2002, Current oncology reports.
[109] S. de Sanjosé,et al. The Epidemiology of Human Papillomavirus Infection and Cervical Cancer , 2007, Disease markers.
[110] S. Lemon,et al. Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer , 2011, Oncogene.
[111] Thomas K. Hazlet,et al. Global Epidemiology of Hepatitis B Virus , 2004, Journal of clinical gastroenterology.
[112] P. Duerksen-Hughes,et al. HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. , 2011, Future virology.
[113] Q. Tao,et al. Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. , 2006, Frontiers in bioscience : a journal and virtual library.
[114] E. Weiderpass,et al. Burkitt's lymphoma in Africa, a review of the epidemiology and etiology. , 2007, African health sciences.
[115] R. Peeling,et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. , 2002, The Journal of infectious diseases.
[116] M. Piazuelo,et al. The future of gastric cancer prevention , 2004, Gastric Cancer.
[117] J. Guarner,et al. Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009 , 2009, European Journal of Pediatrics.
[118] N. Muñoz,et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. , 2007, The Lancet. Infectious diseases.
[119] Elizabeth R Unger,et al. Prevalence of HPV infection among females in the United States. , 2007, JAMA.
[120] J. Groopman,et al. Aflatoxin and hepatitis B virus biomarkers: a paradigm for complex environmental exposures and cancer risk. , 2005, Cancer biomarkers : section A of Disease markers.
[121] R. Chung,et al. Viral hepatocarcinogenesis , 2010, Oncogene.
[122] J. Peto,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.
[123] E. Joura,et al. A Review of its Use in the Prevention of Premalignant Genital Lesions, Genital Cancer and Genital Warts in Women , 2010 .
[124] E. El-Omar,et al. Helicobacter Pylori associated global gastric cancer burden. , 2009, Frontiers in bioscience.
[125] E. Simard,et al. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. , 2010, The Journal of infectious diseases.
[126] M. Plummer,et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.
[127] A. Chaturvedi. Beyond cervical cancer: burden of other HPV-related cancers among men and women. , 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[128] S. Kenney,et al. Virally targeted therapies for EBV-associated malignancies , 2003, Oncogene.
[129] Yong-tang Zheng,et al. Comparison of HIV-, HBV-, HCV- and Co-Infection Prevalence between Chinese and Burmese Intravenous Drug Users of the China-Myanmar Border Region , 2011, PloS one.
[130] M. Tazhibi,et al. Intestinal parasitic infections in renal transplant recipients , 2010 .
[131] D. Lowy,et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[132] M. Fiorentino,et al. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. , 2000, Journal of hepatology.
[133] Fei-Fei Liu,et al. Contributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma , 2011, Journal of Virology.
[134] K. Chayama,et al. Hepatocellular carcinoma: Towards personalized medicine , 2012, Cancer science.
[135] C. Adebamowo,et al. HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data , 2011, Infectious Agents and Cancer.
[136] Louisa Degenhardt,et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.
[137] M. Alter,et al. The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.
[138] Shiyuan Liu,et al. A meta-analysis of case–control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China , 2005, British Journal of Cancer.
[139] H. El-Mahallawy,et al. Hepatitis C virus and its genotypes and Helicobacter pylori in pediatric non-Hodgkin's lymphoma: could there be a possible etiologic role? , 2004, Journal of the Egyptian National Cancer Institute.
[140] M. Stanley. Genital human papillomavirus infections: current and prospective therapies. , 2012, The Journal of general virology.
[141] A. Giordano,et al. Viral infections as a cause of cancer (review). , 2007, International journal of oncology.
[142] C. Shiff,et al. Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. , 2009, The American journal of tropical medicine and hygiene.
[143] K. Manavi. A review on infection with Chlamydia trachomatis. , 2006, Best practice & research. Clinical obstetrics & gynaecology.
[144] F. X. Bosch,et al. The viral etiology of cervical cancer. , 2002, Virus research.
[145] S. Franceschi,et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis , 2005, The Lancet.
[146] A. Ferenczy,et al. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[147] B. Gärtner,et al. EBV viral load detection in clinical virology. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[148] D. Gretch,et al. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection. , 2007, The Journal of infectious diseases.
[149] T. A. Nagy,et al. Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. , 2010, Gastroenterology.
[150] M. Lemoine,et al. HIV/hepatitis B virus co-infection: current challenges and new strategies. , 2010, The Journal of antimicrobial chemotherapy.
[151] Guo-Jing Yang,et al. A Research Agenda for Helminth Diseases of Humans: Intervention for Control and Elimination , 2012, PLoS neglected tropical diseases.
[152] J. Schiller,et al. New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer. , 2002, Journal of the National Cancer Institute.
[153] P Boffetta,et al. A meta‐analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma , 1998, International journal of cancer.
[154] H. Wedemeyer,et al. Hepatitis Delta: Immunopathogenesis and Clinical Challenges , 2010, Digestive Diseases.
[155] Y. Chawla,et al. Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine , 2006, BMC infectious diseases.
[156] A. Nanbo,et al. The role of EBERs in oncogenesis. , 2001, Seminars in cancer biology.
[157] S. Chen,et al. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells , 1993, Journal of virology.
[158] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .
[159] M. Diomande,et al. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in africa , 1998, Cancer.
[160] M. Blaser. Who are we? , 2006, EMBO reports.
[161] A. Pierangeli,et al. Human Papillomaviruses and genital co-infections in gynaecological outpatients , 2009, BMC infectious diseases.
[162] K. Yoo,et al. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: Systematic review and meta‐analysis , 2011, International journal of cancer.
[163] R. Kurzrock,et al. Epstein-Barr Virus and Cancer , 2004, Clinical Cancer Research.
[164] C. Wild,et al. A model of interaction: aflatoxins and hepatitis viruses in liver cancer aetiology and prevention. , 2009, Cancer letters.
[165] Paolo Bonanni,et al. The prevention of infection-associated cancers. , 2011, Carcinogenesis.
[166] C-F Kao,et al. Mechanisms for Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatitis C Virus Core Protein* , 2003, The Journal of Biological Chemistry.
[167] Epidemiology of hepatitis B in the United States , 2007 .
[168] R. Bartenschlager,et al. Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference , 2009, Hepatology.
[169] J. -. Wu,et al. Functional and clinical significance of hepatitis D virus genotype II infection. , 2006, Current topics in microbiology and immunology.
[170] L. Bolondi,et al. High Prevalence of Helicobacter pylori in Liver Cirrhosis (Relationship with Clinical and Endoscopic Features and the Risk of Peptic Ulcer) , 1997, Digestive Diseases and Sciences.
[171] D. Thorley-Lawson. EBV the prototypical human tumor virus--just how bad is it? , 2005, The Journal of allergy and clinical immunology.
[172] P. Khlangwiset,et al. Costs and efficacy of public health interventions to reduce aflatoxin-induced human disease , 2010, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.
[173] L. Young,et al. Epstein–Barr virus infection: basis of malignancy and potential for therapy , 2001, Expert Reviews in Molecular Medicine.
[174] Hugh H. Hussey,et al. Diagnosis of That , 1976 .
[175] G. Raimondo,et al. Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist. , 2008, Journal of hepatology.
[176] Ning Wang,et al. Simultaneous detection of HBV and HCV by multiplex PCR normalization. , 2004, World journal of gastroenterology.
[177] U. Ghoshal,et al. The enigma of Helicobacter pylori infection and gastric cancer , 2010, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[178] R. Miller,et al. HIV infection and lymphoma , 2006, Journal of Clinical Pathology.
[179] B. Shiramizu,et al. High prevalence of human polyomavirus JC VP1 gene sequences in pediatric malignancies. , 2007, Cellular and molecular biology.
[180] J. Dillner,et al. Chlamydia trachomatis infection and persistence of human papillomavirus , 2005, International journal of cancer.
[181] A. Sonnenberg. Birth-cohort patterns of mortality from ulcerative colitis and peptic ulcer. , 2008, Annals of epidemiology.
[182] Hideo Tanaka,et al. Hepatitis B and C Virus Infection and Hepatocellular Carcinoma in China: A Review of Epidemiology and Control Measures , 2011, Journal of epidemiology.
[183] M. Manns,et al. Longer survival of liver transplant recipients with hepatitis virus coinfections , 2007, Clinical transplantation.
[184] T. Wang,et al. Providing AID to p53 mutagenesis , 2007, Nature Medicine.
[185] G. Dore,et al. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C , 2011, Journal of gastroenterology and hepatology.
[186] Ya-jun Tan. Hepatitis B virus infection and the risk of hepatocellular carcinoma. , 2011, World journal of gastroenterology.
[187] Giuseppe Realdi,et al. Helicobacter Infection in Patients with HCV-Related Chronic Hepatitis, Cirrhosis, and Hepatocellular Carcinoma , 2002, Digestive Diseases and Sciences.
[188] S. T. Liu,et al. Detection of Epstein-Barr virus and human papillomavirus in head and neck tumors , 1993, Journal of clinical microbiology.
[189] Wen-Jen Yang,et al. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[190] Harald zur Hausen,et al. Childhood leukemias and other hematopoietic malignancies: Interdependence between an infectious event and chromosomal modifications , 2009 .
[191] H. Adami,et al. Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.
[192] A. Sebestyén,et al. Lymphoproliferative Disorders After Solid Organ Transplantation—Classification, Incidence, Risk Factors, Early Detection and Treatment Options , 2011, Pathology & Oncology Research.
[193] P. Gravitt. The known unknowns of HPV natural history. , 2011, The Journal of clinical investigation.
[194] A. Rickinson,et al. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[195] P. Howley,et al. Repression of the Integrated Papillomavirus E6/E7 Promoter Is Required for Growth Suppression of Cervical Cancer Cells , 2000, Journal of Virology.
[196] T. Bjørge,et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer , 2000, International journal of cancer.
[197] F. Alexander,et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. , 1991, Journal of clinical pathology.
[198] D. Sansonno,et al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low‐grade lymphoma associated with autoimmune disease and in chronic gastritis , 2000, Hepatology.
[199] G. Taylor,et al. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. , 2011, Cancer letters.
[200] B. Mayala,et al. Plasmodium falciparum and helminth coinfections among schoolchildren in relation to agro-ecosystems in Mvomero District, Tanzania. , 2011, Acta tropica.
[201] M. Hatakeyama. Helicobacter pylori and gastric carcinogenesis , 2009, Journal of Gastroenterology.
[202] H. Varmus,et al. Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention , 2011, Science Translational Medicine.
[203] M. Fukayama,et al. Epstein–Barr virus and gastric carcinoma: virus–host interactions leading to carcinoma , 2008, Cancer science.
[204] F. Carrilho,et al. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin. , 2008, Acta tropica.
[205] K. Polman,et al. Helminths and malignancy , 2009, Parasite immunology.
[206] M. Riaz,et al. An overview of Triple infection with Hepatitis B, C and D viruses , 2011, Virology Journal.
[207] J. Hou,et al. Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection , 2006, International journal of medical sciences.
[208] M. Steben,et al. Human papillomavirus infection: epidemiology and pathophysiology. , 2007, Gynecologic oncology.
[209] Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. , 2011, MMWR. Morbidity and mortality weekly report.
[210] L. Young,et al. Epstein-Barr virus-associated cancers: aetiology and treatment. , 2003, Herpes : the journal of the IHMF.
[211] M. Chiasson,et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. , 1997, The New England journal of medicine.
[212] B. Fried,et al. Helminths in human carcinogenesis. , 2011, Cancer letters.
[213] L. Mariani,et al. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study. , 2004, European journal of gynaecological oncology.
[214] Arvind H. Patel,et al. Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies , 2011, Viruses.
[215] M. Wahlgren,et al. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus. , 2009, Seminars in cancer biology.
[216] E. Weiderpass,et al. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study , 2011, Infectious Agents and Cancer.
[217] F. Di Mario,et al. Non-invasive tests in gastric diseases. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[218] P. Ostrosky-Wegman,et al. Role of infectious diseases in human carcinogenesis , 2005, Environmental and molecular mutagenesis.
[219] Pei-Hsin Chen,et al. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[220] H. Kanegane,et al. Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. , 2002, Critical reviews in oncology/hematology.
[221] M. V. Preciado,et al. Characterization of Epstein Barr Virus Latency Pattern in Argentine Breast Carcinoma , 2010, PloS one.
[222] C. Shiff,et al. The Importance of Definitive Diagnosis in Chronic Schistosomiasis, with Reference to Schistosoma haematobium , 2012, Journal of parasitology research.
[223] W. V. van Son,et al. Presentation and early detection of post‐transplant lymphoproliferative disorder after solid organ transplantation , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[224] R. Brunham,et al. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine , 2005, Nature Reviews Immunology.
[225] J. Fishman. Infections in immunocompromised hosts and organ transplant recipients: Essentials , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[226] A. Al Moustafa,et al. Association between human papillomavirus and Epstein-Barr virus infections in human oral carcinogenesis. , 2009, Medical hypotheses.
[227] M. Buti,et al. Role of hepatitis B, C, and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference , 2001, Hepatology.
[228] A. Bankfalvi,et al. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: A 7.5‐year longitudinal study in a routine cytology‐based screening population in West Germany , 2008, Journal of medical virology.
[229] M. Mzibri,et al. Molecular detection and genotyping of human papillomavirus in cervical carcinoma biopsies in an area of high incidence of cancer from Moroccan women , 2009, Journal of medical virology.
[230] M. Epstein,et al. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.
[231] F. Negro,et al. Hepatitis D virus: an update , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[232] A. Kudoh,et al. Latent and lytic Epstein‐Barr virus replication strategies , 2005, Reviews in medical virology.
[233] C. Wild,et al. The toxicology of aflatoxins as a basis for public health decisions. , 2002, Mutagenesis.
[234] F. Mégraud,et al. Review article: the treatment of refractory Helicobacter pylori infection , 2003, Alimentary pharmacology & therapeutics.
[235] R. Ploutz-Snyder,et al. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children , 2008, Malaria Journal.
[236] M. Falagas,et al. Current diagnosis and management of infectious mononucleosis , 2012, Current opinion in hematology.
[237] D. Mant. Prevention , 1994, The Lancet.
[238] D. Graham,et al. Helicobacter pylori treatment in the era of increasing antibiotic resistance , 2010, Gut.
[239] A. Moormann. How might infant and paediatric immune responses influence malaria vaccine efficacy? , 2009, Parasite immunology.
[240] M. Kudo,et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan , 1999, Gut.
[241] M. Blaser,et al. Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.
[242] J. Sullivan,et al. Infectious mononucleosis. , 2010, The New England journal of medicine.
[243] E. Joura,et al. Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine (Gardasil®) , 2010, Drugs.
[244] K. Takada. Epstein-Barr virus and gastric carcinoma , 2000, Molecular pathology : MP.
[245] M. Kojiro,et al. HBsAg‐negative hepatitis B virus infections in hepatitis C virus‐associated hepatocellular carcinoma , 2005, Journal of viral hepatitis.
[246] M. Weltman,et al. Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. , 1995, Journal of viral hepatitis.
[247] H. Higashi,et al. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis , 2005, Cancer science.
[248] S. Franceschi,et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma , 2009, Infectious Agents and Cancer.
[249] R. Khanna,et al. Epstein–Barr virus‐associated Hodgkin's lymphoma , 2004, British journal of haematology.
[250] Y. Yamaoka. Mechanisms of disease: Helicobacter pylori virulence factors , 2010, Nature Reviews Gastroenterology &Hepatology.
[251] Dongchi Zhao,et al. Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis , 2010, Virology Journal.
[252] Blossom Damania,et al. Infectious agents and cancer: criteria for a causal relation. , 2004, Seminars in cancer biology.
[253] Karl Münger,et al. Mechanisms of genomic instability in human cancer: Insights from studies with human papillomavirus oncoproteins , 2004, International journal of cancer.